https://www.selleckchem.com/pr....oducts/k-ras-g12c-in
Udrea et al [1] reported 95.1% sensitivity and 78.3% specificity using the SkinVision app for risk assessment of skin lesions. These are likely to be overestimates due to the nature of the study design and flaws in sampling. This article is protected by copyright. All rights reserved.STUDY AIMS The PillCamTM patency capsule (PPC) is an Agile tag-less patency capsule used to evaluate gastrointestinal (GI) patency. We determined the appropriate use of PPC to preclude subsequent small bowel capsule endoscopy (SBCE) retentio
Like
Comment
Share
